Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sihui Chen

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2023
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancerYiquan Xu, Jingjing Yan, Chengzhi Zhou, et al.
Cancer Letters|July 3, 2026
Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancerSixuan Wu, Senyuan Li, Yaqin Zheng, et al.
Nature Medicine|August 30, 2016
Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in ratsYifeng Zhang, Jiankun Xu, Ye Chun Ruan, et al.
Medcomm|March 11, 2024
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response scoreXinlong Zheng, Tao Lu, Shiwen Wu, et al.
BMC Cancer|December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter studyXinlong Zheng, Longfeng Zhang, Lin Wu, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2023
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancerYiquan Xu, Jingjing Yan, Chengzhi Zhou, et al.
Cancer Letters|July 3, 2026
Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancerSixuan Wu, Senyuan Li, Yaqin Zheng, et al.
Nature Medicine|August 30, 2016
Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in ratsYifeng Zhang, Jiankun Xu, Ye Chun Ruan, et al.
Medcomm|March 11, 2024
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response scoreXinlong Zheng, Tao Lu, Shiwen Wu, et al.
BMC Cancer|December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter studyXinlong Zheng, Longfeng Zhang, Lin Wu, et al.
Pageof 9